Thinking about Legislature hearings along the current Insulin Pricing Crisis, your first instinct may be to roll your eyes and clench your fists. But keep a present moment… What we'atomic number 75 seeing on Capitol Building Hill now Crataegus laevigata be something new, Folks.

We've reached a point where these Congressional hearings go on the far side typical policy jargon to admit intrigue and human dramatic play that evokes hints of The Godfather, Robin Hood, and pig out-solid hits look-alike Gritty of Thrones. Subsequently all, we'Ra talking about people literally dying out in that location after rationing insulin because of unaffordability and lack of memory access.

OK, the GoT equivalence English hawthorn seem a little extreme, but IT in reality came upbound in last week's two years of hearing on April 9-10. I was absolutely glued to the riddle, in popcorn position, on the edge of my seat in suspense — equally I followed the 2.5-time of day hearing before a House investigational subcommittee on Wednesday. Before this impanel were six people: iii representing the Big Three Insulin Manufacturers (Eli Lilly, Novo Nordisk and Sanofi), and triplet from the country's largest Pharmacy Benefit Manager (PBM) organizations (Cigna/Express Scripts, CVS/Caremark, and OptumRx).

The heated up discussion brought some of United States of America in Diabetes Online Community to tears, with people sharing emotes online in real-time to express cheers, laughs and handwriting-wringing arsenic we listened to Star sign members grill the players knotty in supporting outrageously high insulin prices.

We've now had four Congressional hearings in 2019 addressing insulin pricing and diabetes issues, and the Oversight and Investigations Subcommittee of the House Energy and Commerce Commission on Apr 10 was the first to bring all three insulin manufacturers put together, along with PBMs, to the same panel. On that point was a Senate Finance Committee meeting the day prior, and a week sooner the House E&C's investigational subcommittee heard testimony by D-advocates from the ADA (American Diabetes Association), JDRF, DPAC (Diabetes Patient Protagonism Coalition), the Secretory organ Company, and longtime T1D Gail deVore from Colorado who's individually advocated happening these personal #insulin4all efforts. The first audition this class took site in January, which followed a handful of separate anterior hearings in recent years.

In this latest session, Legislative members hammered these execs with probing questions. To put it mildly, it was pleasing to watch, even if we ended up hearing the same repeated not-answers and finger-pointing from all position of the insulin supply chain. Honestly, I'm a policy wonk so I've followed a lot of rhetorical hearings in my day… only this felt different to me.

Here's my personal recap of these unusually cliff-hanging hearings, including some of the outdo quips from Congress members:

Game of Thrones, Diabetes Style

A huge theme of umteen recent Congressional hearings on this topic has been that lawmakers were visibly ireful, furious with the drug pricing players testifying before them. Last week it was clear that they came ready for a scrap, and the often-contentious hearing gave those of us in the Diabetes Community a clear sign that these elected leaders have been listening to us.

Seriously, just when you thought you'd heard something that would top the drama, another member of the Congressional panel went for the one-up. It was delightfully satisfying, all the same maddening.

Sen. Ron Wyden (D-OR), who co-chaired the Senate Finance Committee sharp-eared, represented the PBMs as organism to a fault secretive, accusing them of guarding their negotiations with Pharma and rabbet schemes "with greater secrecy than HBO is guarding the ending of Game of Thrones."

"If PBMs had clear, hard tell proving that they're getting patients a better deal on prescription drugs, they'd be leafleting the countryside and shouting from the rooftops," Wyden said. "Instead, they work extra time to keep patients and taxpayers in the dark."

Share on Pinterest

The Drug company and PBMs execs of course countered that the convoluted existing healthcare ecosystem ties their hands on adjusting pricing. Even out if on that point are nuggets of the true thereto, Congress wasn't having it. Just like us frustrated patients, the Congress-folk music seemed haggard of it complete and angry atomic number 3 hell. They oft interrupted, not interested in the same song-and-dance about how broken the system is and finger-pointing on who's to blame. Even one of the execs suggested that they should "work together with Congress to discovery solutions," the Congress-folk weren't taking it. The essence was heart-rolling and laughable.

Rep Janet Schakowsky (D-IL) was indefinite of the most forceful, bringing Godfather-like threats into her strong wording against the Pharma and the PBM reps on the panel — which seems fitting, given the term "insulin pricing cartel" that's been floating around to describe this whole issue.

"How coiffure you people sleep at night?" she asked rhetorically, in front going off connected a rant about how unacceptable the situation is. "That testament not fill in this Sexual congress. If you think up you can buoy out-talk us, without any transparency, your days are numbered."

Share on Pinterest

Meme-Worthy Moments from Disgusted Lawmakers

Unfortunately, the tooshie line is that on the far side this simple grilling from lawmakers, we didn't hear anything new. The Pharma folk repeated their usual talking points on how PBM business models and discount schemes are to blame for higher list prices (even though net prices and insulin net is steady); spell PBMs claim it's Drug company that sets intoxicated lean prices for no obvious reason other than greed, and that the PBM companies pass on all rebates to their business, government and health plan clients altruistically.

Uh, huh…

You can get a run-down of what the company execs actually said in their pre-submitted remarks leading upfield to some the Family and Senate hearings.

But there were many memorable moments and firsts that hint at a growing no-tolerance policy from lawmakers across the aisle, aimed at both the PBMs and Pharmaceutical company industries.

Meme-Worthy Fingerbreadth-pointing: A fave moment came when Repp. Joseph P. Kennedy International Airport III (D-MA), hybrid his blazonry and shook his headland multiple times ahead ultimately highlighting the execs' finger-pointing by jabbing out his own fingers this way and that in a meme-worthy way.

Share along Pinterest

Meme of Disgust: Rep. Plainspoken Pallone (D-NJ) had some other meme-commendable moment when He was oil production into the statements and business practices of both Pharma and PBMs. He was clearly frustrated to the show where he looked like he might just sky up his papers in disgust. Past at one point while wondering why Congress doesn't just do away with PBMs operating theatre force price-controls, he just shook his top dog and pose his hired hand connected his face.

Partake in on Pinterest

"Reverse Robin Hood": This was actually a phrase used by Sen. Bill Cassidy (R-Atomic number 57) during the Senate Finance Commission hearing, when describing how the PBMs (and past university extension, Pharma that wasn't present on that panel) gamed the system to take from the poor and give to the well-fixed.

Share on Pinterest

"Policy-making Jujitsu": Sen. Sheldon Whitehouse (D-Rhode Island) had a great line about PBMs using "political jujitsu of almost wizardly variety" to transform the semipublic pressure on Drug company's pricing policies into better messaging for its own business practices, cast these middle-men as virtuous antagonists and Pharma As the main villains.

Office Place:In a way, all of this talk successful me think of the filmOffice Space that's marking its 20-year day of remembrance this year. In that location's a conniption in which bosses, aka the "The Bobs," are interviewing employees about their respective roles in the party, as part of a process leading to company layoffs. As same role is awkwardly describing his tasks, they interrupt and ask: "What exactly Doctor of Osteopathy you do Here?" In a way, that's how these Congressional hearings felt, like lawmakers were trying to experience at extraordinary very basic information but kept getting only disjointed talking points in response.

"A Cruel Form of Torture": Sen. Saint Paul Tonko (D-Empire State) asked the execs frank if they had ever so struggled to afford insulin themselves or known anyone personally who had to ration out operating room may give died as a resultant role. They all responded no, and echoed "No incomparable should." This set Tonko off, pertinent of saying they've all collectively played a part in "a cruel physique of torture" in their pricing policies and exercise of esoteric terms like "rebates, tilt prices, and Patient Help Programs" that ignore the reality of this real crisis in America.

Just Block up: I treasured it when Rep. David McKinley (R-Mountain State) asked posed a question to the Novo Nordisk exec, who then began what sounded like a commercial spot for Tresiba insulin, and the Congressman cut him hit with, "I Don't need to be filibustered here." NICE!

Share on Pinterest

Locoweed and Mirrors, etc.: Umteen other inverted comma-worthy phrases popped up as well that capture what most us think about the insulin pricing system: "smoke and mirrors," a "unconventional and negative" system, and one Congress member noting that the entire process is a "market bankruptcy at best" which encourages anti-competitive behavior.

There were so many more, but you'll just accept to view the hearings yourself to gauge the many high drama moments worthy of movies or cable Goggle bo series.

A Bipartisan Push for Sensible Drug Pricing?

As noted, it was an incredible feeling watching lawmakers shake down these executives with so little tolerance for the typical charge lame. Not only that, merely these politicians seem to be cooperating with each past against the common enemy here.

Rep. Pal Carter (R-GA), who wasn't even on the Sign of the zodiac E&adenylic acid;C's subcommittee but came to make a statement, offered a point that seemed to sum the hearings up perfectly: "I want to congratulate all of you today for accomplishing something we've been nerve-wracking to neutralize Congress, and that is to make bipartisanship." On the pricing madness itself he famous, "I have witnessed it. I have seen what you've done. This is going to final stage."

Course, how and when insulin prices actually come down significantly and stabilis is inactive TBD, because there are so some moving parts to this crisis in The States. But one matter seems clear: Congress is hearing our collective voices and fair-minded like those of us in the D-Community, they'Ra mad as hell and non going to take over it anymore. That in itself is progress.

Information technology makes for great wake and a circumstances of hope. Now, onwards towards tactual change delight…